Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

GALT PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 51
  • 0 comments

FDA approve ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Comment Full text

IMPAX LABS INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 50
  • 0 comments

FDA approve NABUMETONE

Comment Full text

SUN PHARM INDS INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 49
  • 0 comments

FDA approve FLURBIPROFEN

Comment Full text

ACTAVIS MID ATLANTIC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 48
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

MICRO LABS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 38
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

RUBICON

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 48
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text

CARLSBAD

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 37
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

PADAGIS US

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 49
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

TARO

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 44
  • 0 comments

FDA approve ETODOLAC

Comment Full text

STEVENS J

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 52
  • 0 comments

FDA approve ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Comment Full text
  • Previous
  • 298
  • 299
  • 300
  • 301
  • 302
  • Next

Search

News categories

  • Technical Exchange News(12372)
  • Event(6229)
  • SEC News(272917)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158397)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin